These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 24893984)

  • 1. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
    Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
    J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium 2-(1-hydroxypentyl)-benzoate promotes long-term potentiation in Aβ1-42-injected rats and APP/PS1 transgenic mice.
    Li PP; Wang WP; Liu ZH; Xu SF; Lu WW; Wang L; Wang XL
    Acta Pharmacol Sin; 2014 Jul; 35(7):869-78. PubMed ID: 24858312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D
    PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The attenuation effect of potassium 2-(1-hydroxypentyl)-benzoate in a mouse model of diabetes-associated cognitive decline: The protein expression in the brain.
    Yu W; Yin H; Sun Y; Shi S; Li J; Wang X
    CNS Neurosci Ther; 2022 Jul; 28(7):1108-1123. PubMed ID: 35445545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.
    Ding Y; Qiao A; Wang Z; Goodwin JS; Lee ES; Block ML; Allsbrook M; McDonald MP; Fan GH
    J Neurosci; 2008 Nov; 28(45):11622-34. PubMed ID: 18987198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of potassium 2-(l-hydroxypentyl)-benzoate on hippocampal neurons, synapses and dystrophic axons in APP/PS1 mice.
    Huang L; Zhang Y; Peng Y; Zhao Z; Zhou Y; Wang X; Peng Y
    Psychopharmacology (Berl); 2019 Sep; 236(9):2761-2771. PubMed ID: 31165206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.
    Zhu C; Xu B; Sun X; Zhu Q; Sui Y
    Mol Neurobiol; 2017 Dec; 54(10):7964-7978. PubMed ID: 27878757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safflower yellow ameliorates cognition deficits and reduces tau phosphorylation in APP/PS1 transgenic mice.
    Ruan YY; Zhai W; Shi XM; Zhang L; Hu YL
    Metab Brain Dis; 2016 Oct; 31(5):1133-42. PubMed ID: 27311611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHPB ameliorates memory deficits and reduces oxidative injury in Alzheimer's disease mouse model by activating Nrf2 signaling pathway.
    Shang NY; Huang LJ; Lan JQ; Kang YY; Tang JS; Wang HY; Li XN; Sun Z; Chen QY; Liu MY; Wen ZP; Feng XH; Wu L; Peng Y
    Acta Pharmacol Sin; 2024 Jun; 45(6):1142-1159. PubMed ID: 38409216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
    Antioxid Redox Signal; 2012 Sep; 17(6):860-77. PubMed ID: 22360429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
    Jin G; Wang LH; Ji XF; Chi TY; Qi Y; Jiao Q; Xu Q; Zhou XY; Zhang R; Zou LB
    Neurosci Lett; 2014 Jun; 573():58-63. PubMed ID: 24810883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
    Zhang H; Chen W; Li Z; Huang Q; Wen J; Chang S; Pei H; Ma L; Li H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116985. PubMed ID: 37532075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
    Zhou D; Liu H; Li C; Wang F; Shi Y; Liu L; Zhao X; Liu A; Zhang J; Wang C; Chen Z
    Metab Brain Dis; 2016 Jun; 31(3):693-703. PubMed ID: 26883430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.